Accéder au contenu
Merck
  • Synthesis of the pyridinyl analogues of dibenzylideneacetone (pyr-dba) via an improved Claisen-Schmidt condensation, displaying diverse biological activities as curcumin analogues.

Synthesis of the pyridinyl analogues of dibenzylideneacetone (pyr-dba) via an improved Claisen-Schmidt condensation, displaying diverse biological activities as curcumin analogues.

Organic & biomolecular chemistry (2011-12-20)
Bin Cao, Yong Wang, Kan Ding, Nouri Neamati, Ya-Qiu Long
RÉSUMÉ

An efficient and easy procedure to synthesize the pyridinyl analogues of dibenzylideneacetone (pyr-dba) was developed by the condensation of substituted nicotinaldehyde and acetone in the presence of K(2)CO(3) in toluene-EtOH-H(2)O solvent system. Structurally diverse pyr-dba, including quinolinyl dba, can be prepared conveniently in moderate to excellent yields under mild conditions with this method. The resulting pyr-dba functioned as the enone analogs of curcumin and efficiently inhibited the activation of NF-κB and the growth of colorectal carcinoma HCT116 p53+/+ cells as well as the HIV-1 IN-LEDGF/p75 interaction.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
4-Phenyl-3-buten-2-one, 99%
Sigma-Aldrich
Benzylideneacetone, ≥98%, FG
Sigma-Aldrich
trans-4-Phenyl-3-buten-2-one, ≥99%